77.1 F
New York
Wednesday, June 16, 2021

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Must read

VEON [NASDAQ: VEON] Announces Acquisition of AdTech in Russia

VEON Ltd disclosed that it has purchased a majority stake in OTM which is a technology platform for the automation and planning of...

MicroStrategy Decides to Sell $1B Stock With Plans To Buy More Bitcoin With Profit

Shares of MicroStrategy Incorporated skyrocketed 5.36% on Wednesday after the firm disclosed that it has decided to dump $1 billion worth of its...

Thailand SEC Forbids Crypto Exchanges from Listing Meme Tokens, NFTs, and More

Thailand SEC has made a new decision that forbids crypto exchanges to list meme tokens, NFTs, and many more. The decision to ban certain...

China’s Cryptocurrency Mining Crackdown Appears to be Widening

The cryptocurrency mining crackdown of China is continuously increasing. It has been seen that government departments in the province of Yunnan are gearing up...

Haemonetics Corporation [NYSE: HAE] revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an upfront payment of $475Million in cash to purchase Cardiva. Furthermore, based on the sales growth the company will pay an additional payment of $35million in conditional consideration.

Cardiva is a California based vascular closure system manufacturer. The portfolio of the company consists of two vascular access site closure devices bases on the catheter. The VASCADE and the VASCADE MVP vascular closure system. The former is designed to treat small-bore femoral and arterial-venous closure Meanwhile the latter is designed to treat mid-bore multi-access femoral venous closure.

VASCADE MVP is the only existing devices that the FDA has approved for the use of cardiac ablation procedures. The acquisition will close in 2021’s first quarter. Moreover, from this acquisition, nearly $65M to $75 M income will be generated in the first fiscal year.  

Cris Simon CEO and president of Haemonetics said “ we are glad to add Cardiva Medical team t our family. We are also really excited to add their technology to our portfolio which expands our hospital offerings”.

More articles

Latest article

Accenture [NYSE: ACN] and Salesforce to Aid ISDI to Reduce its Environmental Impact

Accenture plc and Salesforce have partnered with ISDI to provide aid to the Salesforce-authorized global coaching organization. The firms will evaluate their carbon...

Iconix Brand [NASDAQ: ICON] to be Acquired by Iconix Acquisition Corp

Iconix Brand Group, Inc. disclosed that it has inked an agreement and plan of merger with Iconix Acquisition Corp. Iconix Brand Group is...

Binance Cryptocurrency Exchange to Launch a New NFT Platform

The Binance cryptocurrency exchange will be introducing a new on-chain NFT platform called "Featured by Binance". Cryptocurrency exchange Binance is joining the race of...

El Salvador Passes Bill to Accept Bitcoin as Legal Tender

EI Salvador has become the first country in Central America to pass the bill to accept Bitcoin as legal tender. It has been disclosed...

Gaming Platform Xaya Teams Up with Popular Ethereum Scaling Solution Polygon

Blockchain Gaming platform Xaya has joined hands with popular Ethereum scaling solution Polygon. Xaya has partnered with Polygon to improve the scalability of its...

Why CynergisTek [CTEK] is Skyrocketing Today?

CynergisTek, Inc. skyrocketed 24.73% during the trading session of Wednesday. The positive performance of the firm indicated the positive sentiments of the investors...

GOL Linhas [NYSE: GOL] Announces Acquisition of MAP Transportes Aéreos

Gol Linhas Aereas Inteligentes S.A. disclosed that it has inked an agreement to buy MAP Transportes Aéreos Ltda. The firm's buying decision highlights...

Chinese Twitter ‘Weibo’ Start Crack Down on Multiple Crypto Influencer Accounts

Chinese social media platform Weibo has started a crackdown against the multiple crypto influencer accounts. It has been disclosed that at least dozens of...